✦ LIBER ✦

Summer treatment program for children with attention deficit hyperactivity disorder: Japanese experience in 5 years

✍ Scribed by Yushiro Yamashita; Akiko Mukasa; Chizuru Anai; Yuko Honda; Chie Kunisaki; Junichi Koutaki; Yahuhiro Tada; Chiyomi Egami; Naoko Kodama; Masayuki Nakashima; Shin-ichiro Nagamitsu; Toyojiro Matsuishi

Book ID: 113498952
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 291 KB
Volume: 33
Category: Article
ISSN: 0387-7604
DOI: 10.1016/j.braindev.2010.09.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-term effect of American summer tre

Short-term effect of American summer treatment program for Japanese children with attention deficit hyperactivity disorder

✍ Yushiro Yamashita; Akiko Mukasa; Yuko Honda; Chizuru Anai; Chie Kunisaki; Jun-ic 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Stimulant Medication Effects in a Summer

Stimulant Medication Effects in a Summer Treatment Program Among Young Children With Attention-Deficit/Hyperactivity Disorder

✍ CHACKO, ANIL; PELHAM, WILLIAM E; GNAGY, ELIZABETH M; GREINER, ANDREW; VALLANO, G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 98 KB

P24.12 Effects of Summer Treatment Progr

P24.12 Effects of Summer Treatment Program for children with Attention Deficit/Hyperactivity Disorder on mothers’ affection toward children

✍ S. Mano; H. Uno; Y. Yamashita; T. Matsuishi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Neurofeedback Treatment for Attention-De

Neurofeedback Treatment for Attention-Deficit/Hyperactivity Disorder in Children: A Comparison with Methylphenidate

✍ Thomas Fuchs; Niels Birbaumer; Werner Lutzenberger; John H. Gruzelier; Jochen Ka 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 89 KB

Clinical experience with guanfacine in 2

Clinical experience with guanfacine in 2- and 3-year-old children with Attention Deficit Hyperactivity Disorder

✍ Bernard J. Lee 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

Pediatric pharmacotherapy for 2-and 3-year-olds is not a well-explored area. Psychotropic agents, especially those not approved by the FDA for use in this age group, should only be prescribed after a thorough psychiatric evaluation and careful consideration of other treatment alternatives. This pape

One-year prospective follow-up of pharma

One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder

✍ Anna Didoni; Marco Sequi; Pietro Panei; Maurizio Bonati; on behalf of the “Lomba 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 273 KB